Wellington Management Group LLP decreased its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 8.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,213,825 shares of the company’s stock after selling 1,367,522 shares during the period. Wellington Management Group LLP owned about 1.86% of Colgate-Palmolive worth $1,579,347,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of CL. Park Avenue Securities LLC increased its stake in shares of Colgate-Palmolive by 5.0% during the second quarter. Park Avenue Securities LLC now owns 7,739 shares of the company’s stock valued at $751,000 after acquiring an additional 371 shares during the period. CWM LLC grew its position in Colgate-Palmolive by 18.0% in the second quarter. CWM LLC now owns 27,355 shares of the company’s stock worth $2,655,000 after buying an additional 4,177 shares during the last quarter. Csenge Advisory Group grew its position in Colgate-Palmolive by 8.7% in the second quarter. Csenge Advisory Group now owns 3,734 shares of the company’s stock worth $362,000 after buying an additional 300 shares during the last quarter. Gilman Hill Asset Management LLC acquired a new position in Colgate-Palmolive in the second quarter worth approximately $213,000. Finally, QRG Capital Management Inc. grew its position in Colgate-Palmolive by 11.2% in the second quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after buying an additional 5,751 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Trading Up 0.3 %
NYSE CL opened at $95.10 on Friday. The firm has a market cap of $77.70 billion, a P/E ratio of 27.25, a P/E/G ratio of 3.38 and a beta of 0.43. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock’s 50-day moving average is $96.73 and its 200-day moving average is $98.61. Colgate-Palmolive has a one year low of $75.50 and a one year high of $109.30.
Colgate-Palmolive Dividend Announcement
Wall Street Analysts Forecast Growth
Several research firms have issued reports on CL. Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $105.11.
View Our Latest Stock Analysis on CL
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.34% of the stock is owned by corporate insiders.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- AeroVironment Dives Into a Buying Opportunity
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Ulta Stock Rally: Is There Still Room for More Upside?
- 3 Healthcare Dividend Stocks to Buy
- Buy the Dip? Chewy Stock’s Growth Story Is Far From Over
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.